IGF-1 increases mature collagen in females in mice with systemic MMP8 deficiency and myeloid MMP8 reintroduction. by Patricia Snarski (22305205)

The images of malignant tumors before contrast agent injection, the highest contrast and the contract decreases. by Liang Zhao (94728)

Combination of intraperitoneal and intratumoral administration of vitamin D3 is more effective in reducing the EAC tumor volume compared to just i.p. administration: by Vidya G. Bettada (22208808)

“…Administration of cisplatin (2.5 mg/Kg) and vitamin D3 (125 µg/Kg) significantly decreased the vessel density (CD31) compared to the tumor control group.…”

Reducing Dscam1 diversity decreases adult lifespan in an exon-specific manner, Related to Fig 3. by Haiyang Dong (4783608)

Age-structure model fitting based on data for influenza case and deaths from the 40th week of 2023 to the 17th week of 2024 for three age groups in the United States (i.e. 0–17 yea... by Shuanglin Jing (11886368)

Baseline Characteristics of Included Patients. by Karl Ingard (22582091)

Subjects:

Treatment of cancer cells with vitamin D3 induced death <i>a.</i> by Vidya G. Bettada (22208808)

Juvenile demyelination leads to a substantial decrease in potassium currents in PV interneurons of the PFC. by Sara Hijazi (21656615)

Expression of Caspase-3 in HCT 116 and Hep 3B: <i>2A. and 2B.</i> by Vidya G. Bettada (22208808)

Treatment with vitamin D3 reduced the viability of cancer cell lines: <i>1A & 1B.</i> by Vidya G. Bettada (22208808)

“…Human and rat glioblastoma cell lines U-87 MG and C6, respectively; which were exposed to vitamin D3 demonstrated a statistically significant reduction in viable cells with increasing time and treatment concentration. 1H. …”

Vitamin D3, but not the Cisplatin, could moderately reduce STZ-induced hyperglycemia in mice (a) Schematic representation of experimental protocol followed in the study: After accl... by Vidya G. Bettada (22208808)

“…The data showed a significant increase in fasting blood glucose (FBG) beginning from day 6. …”

Numbers of deaths, mortality rates, and 95% confidence intervals by age group, disease stage, and sex in China in 2021. by Xinyue Qi (9637055)

Subjects:

Numbers of deaths and disability-adjusted life years (DALYs) by disease stage in China from 1990 to 2021. by Xinyue Qi (9637055)

Subjects:

Deaths and DALYs from hepatitis B-related liver diseases in 1990 and 2021 and their change trends from 1990 to 2021. by Xinyue Qi (9637055)

Subjects:

Decomposition analysis of changes in hepatitis B virus (HBV) burden by region (China vs. Global), sex, and disease stage, 1990–2021. by Xinyue Qi (9637055)

Subjects:

Age patterns by sex of the total number and age-specific death rates in 2021. by Xinyue Qi (9637055)

Subjects:

Disability-adjusted life years (DALYs), age-standardized DALY rates (ASDR), and 95% confidence intervals by age group, disease stage, and sex in China in 2021. by Xinyue Qi (9637055)

Subjects:

Age patterns by sex of the total number and age-specific DALYs rate. by Xinyue Qi (9637055)

Subjects:

Age-standardized mortality rates (ASMR), age-standardized disability-adjusted life year rates (ASDR), and their 95% uncertainty intervals (UIs) by disease stage in China from 1990... by Xinyue Qi (9637055)

Subjects:

BAPC model projections of mortality and DALYs rates for each disease stage in China from 2022 to 2035, with 50%, 60%, 70%, 80%, and 95% uncertainty intervals. by Xinyue Qi (9637055)

Subjects: